EW Edwards Lifesciences Corporation

NYSE
$85.52

Edwards Lifesciences Corporation (EW) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with EW's own trailing one-year pace, with 43% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
8
30 transactions
Purchases
$0
0 shares
Sales
$14.3M
171,403 shares
Net activity
-$14.3M
purchases less sales

How much of that selling was preplanned? 43% planned / 57% discretionary

10b5-1 plan sales $6.2M 15 transactions · 77,688 shares
Discretionary sales $8.2M 15 transactions · 93,715 shares

Largest single sale: $2.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Lippis Daniel J. CVP, TAVR Sell 10b5-1 619 $87.51 $54.2K 40,034 −1.5% of holding
Dahl Andrew M. SVP, Corporate Controller Sell 544 $91.06 $49.5K 14,868 −3.5% of holding
Bruls Annette CVP, EMEACLA Sell 2,644 $89.98 $237.9K 17,984 −12.8% of holding
Chopra Daveen 2 fills CVP, TMTT, Surgical & IHFM Sell 31,800 $91.02 $2.9M 74,970 −29.8% of holding
Markowitz Wayne CVP, JAPAC Sell 1,240 $91.47 $113.4K 20,294 −5.8% of holding
Lippis Daniel J. CVP, TAVR Sell 10b5-1 619 $92.03 $57.0K 40,034 −1.5% of holding
Markowitz Wayne CVP, JAPAC Sell 146 $86.03 $12.6K 21,534 −0.7% of holding
Markowitz Wayne CVP, JAPAC Sell 9,628 $85.06 $819.0K 21,680 −30.8% of holding
Zovighian Bernard J CEO Sell 2,921 $83.93 $245.1K 8,916 −24.7% of holding
Lippis Daniel J. CVP, TAVR Sell 10b5-1 619 $91.70 $56.8K 40,034 −1.5% of holding
Lippis Daniel J. CVP, TAVR Sell 10b5-1 619 $91.40 $56.6K 40,411 −1.5% of holding
Zovighian Bernard J CEO Sell 10b5-1 523 $87.92 $46.0K 11,517 −4.3% of holding
Dahl Andrew M. SVP, Corporate Controller Sell 568 $86.08 $48.9K 15,334 −3.6% of holding
BOBO DONALD E JR CVP,Strategy/Corp Development Sell 23,145 $86.42 $2.0M 98,611 −19% of holding
Chopra Daveen CVP, TMTT & Surgical Sell 1,500 $84.60 $126.9K 44,324 −3.3% of holding
Lippis Daniel J. CVP, TAVR Sell 10b5-1 620 $81.14 $50.3K 40,411 −1.5% of holding
BOBO DONALD E JR 2 fills CVP,Strategy/Corp Development Sell 17,968 $81.96 $1.5M 30,970 −36.7% of holding
Zovighian Bernard J 2 fills CEO Sell 10b5-1 36,351 $77.93 $2.8M 47,546 −43.3% of holding
Markowitz Wayne CVP, JAPAC Sell 593 $79.73 $47.3K 21,680 −2.7% of holding
Lippis Daniel J. CVP, TAVR Sell 1,019 $83.98 $85.6K 33,682 −2.9% of holding
Lippis Daniel J. 2 fills CVP, TAVR Sell 10b5-1 1,019 $83.01 $84.6K 34,934 −2.8% of holding
Ullem Scott B. 2 fills CVP, Chief Financial Officer Sell 10b5-1 13,000 $80.04 $1.0M 48,023 −21.3% of holding
Lippis Daniel J. CVP, TAVR Sell 10b5-1 1,019 $80.98 $82.5K 33,934 −2.9% of holding
BOBO DONALD E JR 2 fills CVP,Strategy/Corp Development Sell 10b5-1 22,680 $80.16 $1.8M 39,270 −36.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.